183 related articles for article (PubMed ID: 2162156)
21. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
Vázquez-Abad D; Grodzicky T; Senécal JL
Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
[TBL] [Abstract][Full Text] [Related]
22. [Low prevalence of anti-centromere antibodies in scleroderma in Morocco (about 272 cases)].
Admou B; Arji N; Seghrouchni F; Missoum H; El Fenniri L; Amghar S; El Aouad R
Ann Biol Clin (Paris); 2007; 65(3):291-7. PubMed ID: 17502303
[TBL] [Abstract][Full Text] [Related]
23. Antitopoisomerase and anticentromere antibodies in the sclerodermatosus complex.
Kallenberg CG
Clin Rev Allergy; 1994; 12(3):221-35. PubMed ID: 7804956
[No Abstract] [Full Text] [Related]
24. Cytogenetic survey in systemic sclerosis: correlation of aneuploidy with the presence of anticentromere antibodies.
Jabs EW; Tuck-Muller CM; Anhalt GJ; Earnshaw W; Wise RA; Wigley F
Cytogenet Cell Genet; 1993; 63(3):169-75. PubMed ID: 8387418
[TBL] [Abstract][Full Text] [Related]
25. Identification of a universal B cell epitope on DNA topoisomerase I, an autoantigen associated with scleroderma.
Kato T; Yamamoto K; Takeuchi H; Okubo M; Hara E; Nakada S; Oda K; Ito K; Nishioka K
Arthritis Rheum; 1993 Nov; 36(11):1580-7. PubMed ID: 7694585
[TBL] [Abstract][Full Text] [Related]
26. [Anti-Scl-70 and anti-centromere autoantibodies. Biological markers of 2 forms of systemic scleroderma].
Johanet C; Agostini MM; Vayssairat M; Abuaf N
Presse Med; 1989 Feb; 18(5):207-11. PubMed ID: 2522207
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies to topoisomerase I (Scl-70): analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay.
Hildebrandt S; Weiner ES; Senecal JL; Noell GS; Earnshaw WC; Rothfield NF
Clin Immunol Immunopathol; 1990 Dec; 57(3):399-410. PubMed ID: 2173985
[TBL] [Abstract][Full Text] [Related]
28. [Antinuclear, anticentromere and anti-ScL-70 antibodies in rheumatic diseases].
Ivanova SM; Melkumova KL; Il'in KV; Riazantseva TA; Piven' VA; Speranskiĭ AI
Lab Delo; 1990; (6):50-3. PubMed ID: 1699041
[TBL] [Abstract][Full Text] [Related]
29. Detection of anti-topoisomerase I antibodies using a full length human topoisomerase I recombinant protein purified from a baculovirus expression system.
Whyte J; Earnshaw WC; Champoux JJ; Parker LH; Stewart L; Hall ND; McHugh NJ
Clin Exp Immunol; 1995 May; 100(2):214-8. PubMed ID: 7743657
[TBL] [Abstract][Full Text] [Related]
30. [Anti-Scl-70 antibodies in systemic scleroderma].
Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P
Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650
[TBL] [Abstract][Full Text] [Related]
31. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.
Kuwana M; Kaburaki J; Medsger TA; Wright TM
Arthritis Rheum; 1999 Jun; 42(6):1179-88. PubMed ID: 10366110
[TBL] [Abstract][Full Text] [Related]
32. Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma.
Henry PA; Atamas SP; Yurovsky VV; Luzina I; Wigley FM; White B
Arthritis Rheum; 2000 Dec; 43(12):2733-42. PubMed ID: 11145031
[TBL] [Abstract][Full Text] [Related]
33. Antinuclear antibodies in the relatives of patients with systemic sclerosis.
Takehara K; Moroi Y; Ishibashi Y
Br J Dermatol; 1985 Jan; 112(1):23-33. PubMed ID: 3918553
[TBL] [Abstract][Full Text] [Related]
34. Recruitment of topoisomerase I (Scl-70) to nucleoplasmic proteasomes in response to xenobiotics suggests a role for altered antigen processing in scleroderma.
Chen M; Dittmann A; Kuhn A; Ruzicka T; von Mikecz A
Arthritis Rheum; 2005 Mar; 52(3):877-84. PubMed ID: 15751092
[TBL] [Abstract][Full Text] [Related]
35. Antinuclear antibodies in localized scleroderma.
Takehara K; Moroi Y; Nakabayashi Y; Ishibashi Y
Arthritis Rheum; 1983 May; 26(5):612-6. PubMed ID: 6405756
[TBL] [Abstract][Full Text] [Related]
36. Bibliographical study of the concurrent existence of anticentromere and antitopoisomerase I antibodies.
Kikuchi M; Inagaki T
Clin Rheumatol; 2000; 19(6):435-41. PubMed ID: 11147751
[TBL] [Abstract][Full Text] [Related]
37. Autoantibodies to nucleolar antigens in systemic scleroderma: clinical correlations.
Błaszczyk M; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski T; Kołacińska-Strasz Z; Beutner EH; Kumar V
Br J Dermatol; 1990 Oct; 123(4):421-30. PubMed ID: 2128868
[TBL] [Abstract][Full Text] [Related]
38. [Antibodies against topoisomerase I (Scl-70)--comparative studies on detection with recombinant protein antigens and natural enzyme].
Seelig HP; Schröter H; Ehrfeld H; Renz M
Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):505-11. PubMed ID: 7856253
[No Abstract] [Full Text] [Related]
39. HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies.
Falkner D; Wilson J; Medsger TA; Morel PA
Arthritis Rheum; 1998 Jan; 41(1):74-80. PubMed ID: 9433872
[TBL] [Abstract][Full Text] [Related]
40. Circulating Fc gamma receptor-specific autoantibodies in localized and systemic scleroderma.
Davis K; Boros P; Keltz M; Unkeless JC; Fleischmajer R
J Am Acad Dermatol; 1995 Oct; 33(4):612-6. PubMed ID: 7673494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
